Anindita Chakrabarty - Publications

Affiliations: 
Shiv Nadar University 
Area:
Cancer Biology, Developmental Biology

19 high-probability publications. We are testing a new system for linking publications to authors. You can help! If you notice any inaccuracies, please sign in and mark papers as correct or incorrect matches. If you identify any major omissions or other inaccuracies in the publication list, please let us know.

Year Citation  Score
2024 Haider S, Chakraborty S, Chowdhury G, Chakrabarty A. . Acs Pharmacology & Translational Science. 7: 1237-1251. PMID 38751638 DOI: 10.1021/acsptsci.3c00279  0.647
2024 Taiyab A, Choudhury A, Haidar S, Yousuf M, Rathi A, Koul P, Chakrabarty A, Islam A, Shamsi A, Hassan MI. Exploring MTH1 inhibitory potential of Thymoquinone and Baicalin for therapeutic targeting of breast cancer. Biomedicine & Pharmacotherapy = Biomedecine & Pharmacotherapie. 173: 116332. PMID 38430630 DOI: 10.1016/j.biopha.2024.116332  0.413
2023 Babu G, Das A, Chakrabarty A, Chowdhury G, Goswami M. Criegee Intermediate-Mediated Oxidation of Dimethyl Disulfide: Effect of Formic Acid and Its Atmospheric Relevance. The Journal of Physical Chemistry. A. 127: 8415-8426. PMID 37782474 DOI: 10.1021/acs.jpca.3c04730  0.544
2022 Chakraborty S, Mallick D, Goswami M, Guengerich FP, Chakrabarty A, Chowdhury G. The Natural Products Withaferin A and Withanone from the Medicinal Herb Are Covalent Inhibitors of the SARS-CoV-2 Main Protease. Journal of Natural Products. PMID 36098617 DOI: 10.1021/acs.jnatprod.2c00521  0.529
2021 Chakrabarty A, Surendran S, Bhola NE, Mishra VS, Wani TH, Baghel KS, Arteaga CL, Garg R, Chowdhury G. Corrigendum to: The H1047R PIK3CA oncogene induces a senescence-like state, pleiotropy and acute HSP90 dependency in HER2+ mammary epithelial cells. Carcinogenesis. PMID 34363390 DOI: 10.1093/carcin/bgab065  0.695
2021 Siddiqui S, Ahmed N, Goswami M, Chakrabarty A, Chowdhury G. DNA damage by Withanone as a potential cause of liver toxicity observed for herbal products of (Ashwagandha). Current Research in Toxicology. 2: 72-81. PMID 34345852 DOI: 10.1016/j.crtox.2021.02.002  0.596
2021 Chakrabarty A, Chakraborty S, Bhattacharya R, Chowdhury G. Senescence-Induced Chemoresistance in Triple Negative Breast Cancer and Evolution-Based Treatment Strategies. Frontiers in Oncology. 11: 674354. PMID 34249714 DOI: 10.3389/fonc.2021.674354  0.667
2021 Wani TH, Chowdhury G, Chakrabarty A. Generation of reactive oxygen species is the primary mode of action and cause of survivin suppression by sepantronium bromide (YM155). Rsc Medicinal Chemistry. 12: 566-578. PMID 34046628 DOI: 10.1039/d0md00383b  0.751
2020 Ahmed N, Chakrabarty A, Guengerich FP, Chowdhury G. Protective Role of Glutathione Against Peroxynitrite-Mediated DNA Damage During Acute Inflammation. Chemical Research in Toxicology. PMID 32894672 DOI: 10.1021/Acs.Chemrestox.0C00299  0.654
2020 Kumari P, Mishra VS, Narayana C, Khanna A, Chakrabarty A, Sagar R. Design and efficient synthesis of pyrazoline and isoxazole bridged indole C-glycoside hybrids as potential anticancer agents. Scientific Reports. 10: 6660. PMID 32313038 DOI: 10.1038/S41598-020-63377-X  0.339
2019 Chakrabarty A, Surendran S, Bhola NE, Mishra VS, Wani TH, Baghel KS, Arteaga CL, Garg R, Chowdhury G. The H1047R PIK3CA oncogene induces a senescence-like state, pleiotropy and acute HSP90 dependency in HER2+ mammary epithelial cells. Carcinogenesis. PMID 31219154 DOI: 10.1093/Carcin/Bgz118  0.714
2018 Wani TH, Surendran S, Mishra VS, Chaturvedi J, Chowdhury G, Chakrabarty A. Adaptation to chronic exposure to sepantronium bromide (YM155), a prototypical survivin suppressant is due to persistent DNA damage-response in breast cancer cells. Oncotarget. 9: 33589-33600. PMID 30323901 DOI: 10.18632/Oncotarget.26096  0.737
2018 Wani TH, Surendran S, Jana A, Chakrabarty A, Chowdhury G. The Quinone Based Antitumor Agent Sepantronium Bromide (YM155) Causes Oxygen Independent Redox Activated Oxidative DNA Damage. Chemical Research in Toxicology. PMID 29897742 DOI: 10.1021/Acs.Chemrestox.8B00094  0.723
2018 Kandasamy G, Sudame A, Bhati P, Chakrabarty A, Maity D. Systematic investigations on heating effects of carboxyl-amine functionalized superparamagnetic iron oxide nanoparticles (SPIONs) based ferrofluids for in vitro cancer hyperthermia therapy Journal of Molecular Liquids. 256: 224-237. DOI: 10.1016/J.Molliq.2018.02.029  0.309
2017 Kandasamy G, Sudame A, Bhati P, Chakrabarty A, Kale SN, Maity D. Systematic magnetic fluid hyperthermia studies of carboxyl functionalized hydrophilic superparamagnetic iron oxide nanoparticles based ferrofluids. Journal of Colloid and Interface Science. 514: 534-543. PMID 29289736 DOI: 10.1016/J.Jcis.2017.12.064  0.302
2017 Wani TH, Chakrabarty A, Shibata N, Yamazaki H, Guengerich FP, Chowdhury G. The Dihydroxy Metabolite of the Teratogen Thalidomide Causes Oxidative DNA Damage. Chemical Research in Toxicology. PMID 28745489 DOI: 10.1021/Acs.Chemrestox.7B00127  0.74
2016 Kandasamy G, Surendran S, Chakrabarty A, Kale SN, Maity D. Facile synthesis of novel hydrophilic and carboxyl-amine functionalized superparamagnetic iron oxide nanoparticles for biomedical applications Rsc Advances. 6: 99948-99959. DOI: 10.1039/C6Ra18567C  0.567
2013 Chakrabarty A, Bhola NE, Sutton C, Ghosh R, Kuba MG, Dave B, Chang JC, Arteaga CL. Trastuzumab-resistant cells rely on a HER2-PI3K-FoxO-survivin axis and are sensitive to PI3K inhibitors. Cancer Research. 73: 1190-200. PMID 23204226 DOI: 10.1158/0008-5472.Can-12-2440  0.318
2011 Ghosh R, Narasanna A, Wang SE, Liu S, Chakrabarty A, Balko JM, González-Angulo AM, Mills GB, Penuel E, Winslow J, Sperinde J, Dua R, Pidaparthi S, Mukherjee A, Leitzel K, et al. Trastuzumab has preferential activity against breast cancers driven by HER2 homodimers. Cancer Research. 71: 1871-82. PMID 21324925 DOI: 10.1158/0008-5472.Can-10-1872  0.325
Show low-probability matches.